MICKLE TRAVIS C (President & CEO) purchased 6.6% of their position (2.25K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $18.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/23/2021ACC: 0001437749-21-027301
DirectorOfficer10% Owner· President & CEO
Since Oct 2018
+2.25K
Net shares
Net buyer
$18.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.25K
Price / share
$8.23
Trade value
$18.52K
% of position
6.6%
11/18/2021
34.27K→36.52K
Total
Net shares
+2.25K
Net value
$18.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2021 | P · Purchase | +2.25K | $8.23 | $18.52K | 6.6% | 34.27K | 36.52K |
| Total | +2.25K | $18.52K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned15.24K
Common Stock
IndirectShares owned9.82K
Common Stock
IndirectShares owned1.03K
Common Stock
IndirectShares owned96.15K
Total
122.25K indirect122.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.24K | Indirect |
| Common Stock | 9.82K | Indirect |
| Common Stock | 1.03K | Indirect |
| Common Stock | 96.15K | Indirect |
| Total | 122.25K | 122.25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported